Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

TINC spring 2017

Reference number
Coordinator 1928 DIAGNOSTICS AB
Funding from Vinnova SEK 108 000
Project duration April 2017 - September 2017
Status Completed
Venture Acceleration TINC

Purpose and goal

The aim of attending the TINC program in Silicon Valley was to evaluate product market fit for 1928 Ds products, estimate scaling potential and increase our network with focus on customers, collaborations and investors.

Expected results and effects

There is a need and interest for 1928 Ds products in the US healthcare segment and the company will now scale and adjust activities to prepare for US market entrance.

Planned approach and implementation

To perform analyses we arranged meeting and interviewed customers, potentail collaborators, future employees, investors and KOL. We also attended workshops and seminars to increase knowledge in areas such as marketing sales and company scaling processes.

External links

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 25 November 2019

Reference number 2017-03328

Page statistics